MICRORNA PATHWAY (PW:0000808)
Description
Small non-coding RNAs have emerged as potent regulators of gene expression. Of the three classes - microRNA (miRNA), endogenous small interfering RNA (endo-siRNA) and Piwi-interacting RNA (piRNA), miRNA is the better understood system. Its main function is post-transcriptional repression of target genes. miRNAs are transcribed from individual genes or from the introns of intron-containing genes. The resulting primary miRNA transcript (pri-miRNA) contains a hairpin-loop structure with single stranded arms flanking the hairpin. Many have a cap and a polyA tail indicative of polymerase II transcription. The majority of miRNA are products of pol II transcription; less frequently, of pol III. In the nucleus, the pri-miRNA is cleaved to a ~60-70 nucleotides stem-looped precursor (pre-miRNA) by the microprocessor complex. The core components of the complex are the RNase III Drosha (Rnasen) and its cofactor Dgcr8, essential for determining the cleavage site. The two RNase domains of the enzyme cleave the 5¿ and 3¿ single strands about 11 bp away from the junction of single- and double-stranded RNA. In a Drosha-independent manner, miRNAs can be generated from pre-miRNA-like introns, called mirtrons; the Drosha-mediated route is the canonical miRNA pathway. pre-miRNA is recognized by Xpo5 - a member of the nuclear transport receptor family which, in conjunction with GTP-bound Ran, transports it into the cytoplasm. The
HEAT repeats of Xpo5 are important for both pre-miRNA and GTP-Ran binding. Hydrolysis of GTP to GDP in the cytoplasm leads to release of cargo. In the cytosol, pre-miRNA is processed by Dicer1 - the other RNase III in the pathway. Dicer1, aided by Tarbp2 (Trbp), cleaves the hairpin-loop of pre-miRNA to produce a ~22 nucleotide duplex. Binding of Tarbp2 to the helicase-like domain of Dicer induces conformational changes that abrogate its inhibitory effect. The relative thermodynamic stability of the base pairs at the ends of the duplex determines which strand will become the mature or guide strand. The strand with the less stable 5'end becomes the guide of the miRNA-induced silencing complex (RISC) - the effector complex of miRNA pathway. Members of the argonaute family of proteins are core components of RISC complex; its assembly however, is not well understood and appears to vary between species. In mammals, four proteins of the AGO subfamily with redundant functions are involved in miRNA and siRNA pathways. The ~100kDa proteins contain characteristic
PAZ , MID (middle) and
PIWI domains; PAZ and MID contact the 3' and 5' end of miRNA, respectively. The C-terminal PIWI domain may have endonucleolytic activity, while the N-terminal domain facilitates duplex unwinding. Drosha and Dicer1 generate varied length products; these other length variants, called isomiRs may vary in their gene expression regulation or may regulate the same targets as the canonical miRNAs.
miRNAs and target mRNAs form partially complementary duplexes with the 5' 2-7 nucleotide 'seed' sequence of miRNA and the 3' UTR sequence of target mRNA. Although the 3'UTR was believed to be the major miRNA binding site, recent results indicate that miRNA binding sites may be located within the 5'UTR and the coding sequence (CDS). The translational repression of target genes may occur at the initiation and post initiation steps; the molecular mechanisms are poorly understood. miRNA can also mediate destabilization of mRNA by inducing its deadenylation, leading to decapping and degradation. Tnrc6 (GW182) proteins - the second component of RISC acting downstream of AGO, contact AGOs via the N-terminal GW repeats; the glycine-tryptophan or tryptophan-glycine repeats (GW/WG) are a characteristic feature of the proteins. The N-terminal repeats contain multiple, independent binding sites for AGO referred to as AGO hooks. N- and C-terminal repeats interact with Cnot1 and C-terminal repeats and PAM2 motif interact with Pan3 - subunits of CCR4-NOT and PAN2-PAN3 deadenylase complexes, respectively. The C-terminal region of fly and mammalian proteins also contains a glutamine (Q)-rich domain, a ubiquitin binding domain (UBA), the PAM2 motif and the non-canonical RNA recognition motif (RRM). PAM2 motif also interacts with the poly A binding protein Pabpc1. The PAM2 motif of Pan3 binds Pabpc1, which stimulates the catalytic activity of the complex. Deadenylation is accompanied by decapping via Dcp1-Dcp2 complex, followed by Xrn1 mediated degradation. Dcp2 catalyzes the hydrolysis of the 5' cap structure, Dcp1 is its main activator. Additional activators/decapping factors are present, of which some are species specific. The association of a subset of these factors with miRNA targets is promoted by RISC via both AGO and Tnrc6 mediated interactions. Editing of RNA molecule can serve as a control and regulate the pathway: deamination of adenosine to inosine can affect processing by either RNase processing or, in some cases, result in differential targeting; 3' uridylation can inhibit or promote the activity of Dicer but largely, has an inhibitory effect. Of the three deaminases, Adar (Adar1) and Adarb1 (Adar2) are ubiquitously expressed and have multiple isoforms, of which some shuttle between the nucleus and cytoplasm. Uridylation is carried out by two cytoplasmic uridyl transferases: Zcchc6 (TUT7) and Zcchc11 (TUT4). In addition, miRNAs appear to be involved in the control of their own biogenesis. The molecular mechanisms of these regulatory layers remain to be elucidated, Aberrant expression of miRNAs has been observed for many conditions including various types of cancer.To see the ontology report for annotations, GViewer and download click here ...(less)
Pathway Diagram:
Genes in Pathway:
G
Adar
adenosine deaminase, RNA-specific
ISO
RGD
PMID:22001383
RGD:9850105
NCBI chr 2:175,138,391...175,178,280
Ensembl chr 2:175,138,403...175,178,282
G
Adarb1
adenosine deaminase, RNA-specific, B1
ISO
RGD
PMID:22001383
RGD:9850105
NCBI chr20:11,222,569...11,350,854
Ensembl chr20:11,222,583...11,350,852
G
Ago1
argonaute RISC component 1
ISO
RGD
PMID:20484662
RGD:4144862
NCBI chr 5:138,722,111...138,757,118
Ensembl chr 5:138,722,111...138,773,546
G
Ago2
argonaute RISC catalytic component 2
ISO
RGD
PMID:20484662
RGD:4144862
NCBI chr 7:105,018,202...105,105,118
Ensembl chr 7:105,029,120...105,104,974
G
Ago3
argonaute RISC catalytic component 3
ISO
RGD
PMID:20484662
RGD:4144862
NCBI chr 5:138,632,367...138,714,230
Ensembl chr 5:138,639,569...138,714,230
G
Ago4
argonaute RISC component 4
ISO
RGD
PMID:20484662
RGD:4144862
NCBI chr 5:138,780,446...138,825,898
Ensembl chr 5:138,783,069...138,825,632
G
Cnot1
CCR4-NOT transcription complex, subunit 1
ISO
RGD
PMID:23337855
RGD:9850101
NCBI chr19:9,255,190...9,346,574
Ensembl chr19:9,255,194...9,346,574
G
Cnot10
CCR4-NOT transcription complex, subunit 10
ISO
RGD
PMID:23337855
RGD:9850101
NCBI chr 8:114,280,486...114,330,110
Ensembl chr 8:114,280,490...114,330,107
G
Cnot2
CCR4-NOT transcription complex, subunit 2
ISO
RGD
PMID:23337855
RGD:9850101
NCBI chr 7:52,130,445...52,222,338
Ensembl chr 7:52,130,441...52,223,575
G
Cnot3
CCR4-NOT transcription complex, subunit 3
ISO
RGD
PMID:23337855
RGD:9850101
NCBI chr 1:65,555,924...65,572,167
Ensembl chr 1:65,555,924...65,572,167
G
Cnot6
CCR4-NOT transcription complex, subunit 6
ISO
RGD
PMID:23337855
RGD:9850101
NCBI chr10:33,978,785...34,031,025
Ensembl chr10:33,980,831...34,031,025
G
Cnot6l
CCR4-NOT transcription complex, subunit 6-like
ISO
RGD
PMID:23337855
RGD:9850101
NCBI chr14:13,410,499...13,502,511
Ensembl chr14:13,411,281...13,498,203
G
Cnot7
CCR4-NOT transcription complex, subunit 7
ISO
RGD
PMID:23337855
RGD:9850101
NCBI chr16:51,775,416...51,794,581
Ensembl chr16:51,775,412...51,794,576
G
Cnot8
CCR4-NOT transcription complex, subunit 8
ISO
RGD
PMID:23337855
RGD:9850101
NCBI chr10:42,281,614...42,294,740
Ensembl chr10:42,281,722...42,294,730
G
Cnot9
CCR4-NOT transcription complex subunit 9
ISO
RGD
PMID:23337855
RGD:9850101
NCBI chr 9:76,084,269...76,109,111
Ensembl chr 9:76,084,334...76,109,100
G
Dcp1b
decapping mRNA 1B
ISO
RGD
PMID:24352420
RGD:9850104
NCBI chr 4:152,358,267...152,395,747
Ensembl chr 4:152,358,241...152,397,145
G
Dcp2
decapping mRNA 2
ISO
RGD
PMID:24352420
RGD:9850104
NCBI chr18:36,750,732...36,787,067
Ensembl chr18:36,750,732...36,788,557
G
Ddx6
DEAD-box helicase 6
ISO
RGD
PMID:24352420
RGD:9850104
NCBI chr 8:44,931,127...44,967,773
Ensembl chr 8:44,931,974...44,964,405
G
Dgcr8
DGCR8 microprocessor complex subunit
ISO
RGD
PMID:20661255
RGD:4144851
NCBI chr11:82,704,673...82,737,251
Ensembl chr11:82,704,729...82,737,242
G
Dicer1
dicer 1 ribonuclease III
ISO
RGD
PMID:20661255
RGD:4144851
NCBI chr 6:123,627,529...123,692,278
Ensembl chr 6:123,631,250...123,693,965
G
Drosha
drosha ribonuclease III
ISO
RGD
PMID:20661255
RGD:4144851
NCBI chr 2:61,864,886...61,976,688
Ensembl chr 2:61,864,970...61,976,688
G
Edc3
enhancer of mRNA decapping 3
ISO
RGD
PMID:24352420
RGD:9850104
NCBI chr 8:58,106,147...58,151,685
Ensembl chr 8:58,106,175...58,151,671
G
Edc4
enhancer of mRNA decapping 4
ISO
RGD
PMID:24352420
RGD:9850104
NCBI chr19:33,774,062...33,786,054
Ensembl chr19:33,774,055...33,787,758
G
Pabpc1
poly(A) binding protein, cytoplasmic 1
ISO
RGD
PMID:23337855
RGD:9850101
NCBI chr 7:67,777,438...67,789,731
Ensembl chr 7:67,777,381...67,789,744
G
Pan2
poly(A) specific ribonuclease subunit PAN2
ISO
RGD
PMID:23337855
RGD:9850101
NCBI chr 7:729,146...747,744
Ensembl chr 7:729,562...747,744
G
Pan3
poly(A) specific ribonuclease subunit PAN3
ISO
RGD
PMID:23337855
RGD:9850101
NCBI chr12:7,476,707...7,595,384
Ensembl chr12:7,476,697...7,599,204
G
Patl1
PAT1 homolog 1, processing body mRNA decay factor
ISO
RGD
PMID:24352420
RGD:9850104
NCBI chr 1:208,831,115...208,862,904
Ensembl chr 1:208,831,115...208,862,857
G
Ran
RAN, member RAS oncogene family
ISO
RGD
PMID:19965479
RGD:4144860
NCBI chr12:27,674,049...27,678,598
Ensembl chr12:27,674,050...27,678,276
G
Tarbp2
Tarbp2 subunit of RISC loading complex
ISO
RGD
PMID:20661255
RGD:4144851
NCBI chr 7:133,649,118...133,654,306
Ensembl chr 7:133,649,090...133,654,314
G
Tnrc6a
trinucleotide repeat containing adaptor 6A
ISO
RGD
PMID:20484662
RGD:4144862
NCBI chr 1:177,561,898...177,715,669
Ensembl chr 1:177,646,030...177,715,660
G
Tnrc6b
trinucleotide repeat containing adaptor 6B
ISO
RGD
PMID:20484662
RGD:4144862
NCBI chr 7:112,252,351...112,469,829
Ensembl chr 7:112,252,359...112,461,790
G
Tnrc6c
trinucleotide repeat containing adaptor 6C
ISO
RGD
PMID:20484662
RGD:4144862
NCBI chr10:102,908,958...102,979,543
Ensembl chr10:102,868,828...102,978,194
G
Tut4
terminal uridylyl transferase 4
ISO
RGD
PMID:23622238
RGD:9850106
NCBI chr 5:123,201,723...123,306,582
Ensembl chr 5:123,203,003...123,306,465
G
Tut7
terminal uridylyl transferase 7
ISO
RGD
PMID:23622238
RGD:9850106
NCBI chr17:4,849,287...4,903,542
Ensembl chr17:4,849,283...4,903,169
G
Xpo5
exportin 5
ISO
RGD
PMID:19965479
RGD:4144860
NCBI chr 9:14,740,182...14,778,171
Ensembl chr 9:14,740,182...14,778,171
Pathway Gene Annotations
Disease Annotations Associated with Genes in the microRNA pathway
Adar Acute Lung Injury , Aicardi-Goutieres syndrome , Aicardi-Goutieres Syndrome 6 , anxiety disorder , Breast Neoplasms , cervical squamous cell carcinoma , Charcot-Marie-Tooth disease type 2 , Chronic Hepatitis B , Chronic Hepatitis C , colorectal cancer , combined immunodeficiency , combined T cell and B cell immunodeficiency , dyschromatosis symmetrica hereditaria , ectodermal dysplasia , gastrointestinal stromal tumor , genetic disease , immunodeficiency 42 , learning disability , liver cirrhosis , MHC class II deficiency , microcephaly , papillomavirus infectious disease , parathyroid carcinoma , Salmonella Infections, Animal , severe congenital neutropenia 3 , severe congenital neutropenia 5 , stomach cancer , Viral Myocarditis Adarb1 amyotrophic lateral sclerosis , autistic disorder , Axenfeld-Rieger syndrome type 3 , cataract 9 multiple types , developmental and epileptic encephalopathy 30 , genetic disease , homocystinuria , microcephaly , Neurodevelopmental Disorder with Hypotonia, Microcephaly, and Seizures , Neurodevelopmental Disorders , obesity , polycystic ovary syndrome , primary ciliary dyskinesia , progressive myoclonus epilepsy , Spinal Cord Injuries , syndromic intellectual disability , transient cerebral ischemia , visual epilepsy Ago1 alcohol dependence , Charcot-Marie-Tooth disease dominant intermediate C , genetic disease , intellectual disability , malignant mesothelioma , NEURODEVELOPMENTAL DISORDER WITH LANGUAGE DELAY AND BEHAVIORAL ABNORMALITIES, WITH OR WITHOUT SEIZURES , Neurodevelopmental Disorders Ago2 alcohol dependence , Cocaine-Related Disorders , genetic disease , glaucoma , LESSEL-KREIENKAMP SYNDROME , malignant mesothelioma , morphine dependence , myeloid leukemia , Neurodevelopmental Disorders , primary ovarian insufficiency 3 , withdrawal disorder Ago3 Charcot-Marie-Tooth disease dominant intermediate C Ago4 Charcot-Marie-Tooth disease dominant intermediate C Cnot1 alopecia-mental retardation syndrome 4 , Bardet-Biedl syndrome , developmental and epileptic encephalopathy , early infantile epileptic encephalopathy , epilepsy , genetic disease , holoprosencephaly , holoprosencephaly 12 , intellectual disability , Neurodevelopmental Disorders , Preterm Intraventricular Hemorrhage , Vissers-Bodmer syndrome Cnot2 genetic disease , Intellectual Developmental Disorder with Nasal Speech, Dysmorphic Facies, and Variable Skeletal Anomalies , Neurodevelopmental Disorders Cnot3 autism spectrum disorder , Developmental Disabilities , genetic disease , Intellectual Developmental Disorder with Speech Delay, Autism, and Dysmorphic Facies , intellectual disability , Prostatic Neoplasms , T-cell acute lymphoblastic leukemia Cnot7 hereditary spastic paraplegia 53 , male infertility Cnot9 alacrima, achalasia, and impaired intellectual development syndrome , cerebrotendinous xanthomatosis , gastric adenocarcinoma , hepatocellular carcinoma , myofibrillar myopathy 1 , Neurodevelopmental Disorders , paroxysmal nonkinesigenic dyskinesia 1 , prostate adenocarcinoma , skin melanoma , transitional cell carcinoma Dcp1b Hyperphosphatemic Familial Tumoral Calcinosis 1 , long QT syndrome Dcp2 familial adenomatous polyposis 1 , Hereditary Neoplastic Syndromes , Neurodevelopmental Disorders Ddx6 CD3epsilon deficiency , Chromosome 11, Partial Trisomy 11q , Dwarfism , genetic disease , glycogen storage disease Ib , immunodeficiency 17 , immunodeficiency 18 , immunodeficiency 19 , inflammatory bowel disease 28 , INTELLECTUAL DEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND DYSMORPHIC FACIES , isolated microphthalmia 5 , long QT syndrome 10 , RASopathy , rheumatoid arthritis , teratoma Dgcr8 alcohol dependence , autism spectrum disorder , autistic disorder , chromosome 22q11.2 deletion syndrome, distal , chromosome 22q11.2 microduplication syndrome , DiGeorge syndrome , disease of mental health , epilepsy , hemorrhagic disease , intellectual disability , megacolon , nephroblastoma , Neurodevelopmental Disorders , primary immunodeficiency disease , schizophrenia , velocardiofacial syndrome , Venous Thrombosis Dicer1 autosomal recessive nonsyndromic deafness 111 , breast cancer , Breast Neoplasms , colorectal cancer , congenital disorder of glycosylation Ii , diabetes mellitus , DICER1 syndrome , diffuse large B-cell lymphoma , DiGeorge syndrome , dilated cardiomyopathy , Embryonal Rhabdomyosarcoma 2 , endometriosis , Global Developmental Delay, Lung Cysts, Overgrowth, and Wilms Tumor , hepatocellular carcinoma , Hereditary Neoplastic Syndromes , infertility , Liver Neoplasms , lung cancer , medulloblastoma , microphthalmia , middle cerebral artery infarction , Multinodular Goiter 1 , nephroblastoma , nephroma , oligospermia , ovarian cancer , Pierson syndrome , pineoblastoma , pleuropulmonary blastoma , retinoblastoma , rhabdomyosarcoma , stomach cancer , supratentorial primitive neuroectodermal tumor , syndromic microphthalmia 5 Drosha esophageal atresia , hepatoblastoma , hereditary breast ovarian cancer syndrome , male infertility , nephroblastoma , Neurodevelopmental Disorders Edc3 autosomal recessive intellectual developmental disorder 50 , Bardet-Biedl syndrome , Bloom syndrome , colorectal cancer , schizophrenia Edc4 autosomal dominant dyskeratosis congenita 6 Pabpc1 Breast Neoplasms , Cohen syndrome , COVID-19 , Pulmonary Atresia , teratoma , transitional cell carcinoma , urinary bladder cancer Pan2 Chemical and Drug Induced Liver Injury , cholestasis Patl1 intellectual disability , leukocyte adhesion deficiency 3 Ran Animal Mammary Neoplasms , carcinoma , Experimental Mammary Neoplasms , human immunodeficiency virus infectious disease , Keloid , osteoarthritis , sciatic neuropathy , type 1 diabetes mellitus Tarbp2 Microsatellite Instability , Neurodevelopmental Disorders Tnrc6a familial adult myoclonic epilepsy 6 , Myoclonic Epilepsies Tnrc6b adenylosuccinase lyase deficiency , autism spectrum disorder , Developmental Disabilities , Developmental Disease , genetic disease , GLOBAL DEVELOPMENTAL DELAY WITH SPEECH AND BEHAVIORAL ABNORMALITIES , neurodevelopmental disorder with dysmorphic facies and distal limb anomalies , Neurodevelopmental Disorders , polycystic ovary syndrome , subserous uterine fibroid , uterine fibroid Tnrc6c COVID-19 , epidermodysplasia verruciformis , intellectual disability Tut4 breast cancer , liver benign neoplasm Xpo5 breast cancer , colorectal cancer , hepatocellular carcinoma , Huntington's disease , infantile Refsum disease , Lead Poisoning , lung non-small cell carcinoma , lung small cell carcinoma , Microsatellite Instability , multiple myeloma , nephroblastoma , nephrotic syndrome type 2 , pancreatic cancer , primary ovarian insufficiency , transitional cell carcinoma , Zellweger syndrome
Acute Lung Injury Adar adenylosuccinase lyase deficiency Tnrc6b Aicardi-Goutieres syndrome Adar Aicardi-Goutieres Syndrome 6 Adar alacrima, achalasia, and impaired intellectual development syndrome Cnot9 alcohol dependence Ago1 , Ago2 , Dgcr8 alopecia-mental retardation syndrome 4 Cnot1 amyotrophic lateral sclerosis Adarb1 Animal Mammary Neoplasms Ran anxiety disorder Adar autism spectrum disorder Cnot3 , Dgcr8 , Tnrc6b autistic disorder Adarb1 , Dgcr8 autosomal dominant dyskeratosis congenita 6 Edc4 autosomal recessive intellectual developmental disorder 50 Edc3 autosomal recessive nonsyndromic deafness 111 Dicer1 Axenfeld-Rieger syndrome type 3 Adarb1 Bardet-Biedl syndrome Cnot1 , Edc3 Bloom syndrome Edc3 breast cancer Dicer1 , Tut4 , Xpo5 Breast Neoplasms Adar , Dicer1 , Pabpc1 carcinoma Ran cataract 9 multiple types Adarb1 CD3epsilon deficiency Ddx6 cerebrotendinous xanthomatosis Cnot9 cervical squamous cell carcinoma Adar Charcot-Marie-Tooth disease dominant intermediate C Ago1 , Ago3 , Ago4 Charcot-Marie-Tooth disease type 2 Adar Chemical and Drug Induced Liver Injury Pan2 cholestasis Pan2 Chromosome 11, Partial Trisomy 11q Ddx6 chromosome 22q11.2 deletion syndrome, distal Dgcr8 chromosome 22q11.2 microduplication syndrome Dgcr8 Chronic Hepatitis B Adar Chronic Hepatitis C Adar Cocaine-Related Disorders Ago2 Cohen syndrome Pabpc1 colorectal cancer Adar , Dicer1 , Edc3 , Xpo5 combined immunodeficiency Adar combined T cell and B cell immunodeficiency Adar congenital disorder of glycosylation Ii Dicer1 COVID-19 Pabpc1 , Tnrc6c developmental and epileptic encephalopathy Cnot1 developmental and epileptic encephalopathy 30 Adarb1 Developmental Disabilities Cnot3 , Tnrc6b Developmental Disease Tnrc6b diabetes mellitus Dicer1 DICER1 syndrome Dicer1 diffuse large B-cell lymphoma Dicer1 DiGeorge syndrome Dgcr8 , Dicer1 dilated cardiomyopathy Dicer1 disease of mental health Dgcr8 Dwarfism Ddx6 dyschromatosis symmetrica hereditaria Adar early infantile epileptic encephalopathy Cnot1 ectodermal dysplasia Adar Embryonal Rhabdomyosarcoma 2 Dicer1 endometriosis Dicer1 epidermodysplasia verruciformis Tnrc6c epilepsy Cnot1 , Dgcr8 esophageal atresia Drosha Experimental Mammary Neoplasms Ran familial adenomatous polyposis 1 Dcp2 familial adult myoclonic epilepsy 6 Tnrc6a gastric adenocarcinoma Cnot9 gastrointestinal stromal tumor Adar genetic disease Adar , Adarb1 , Ago1 , Ago2 , Cnot1 , Cnot2 , Cnot3 , Ddx6 , Tnrc6b glaucoma Ago2 GLOBAL DEVELOPMENTAL DELAY WITH SPEECH AND BEHAVIORAL ABNORMALITIES Tnrc6b Global Developmental Delay, Lung Cysts, Overgrowth, and Wilms Tumor Dicer1 glycogen storage disease Ib Ddx6 hemorrhagic disease Dgcr8 hepatoblastoma Drosha hepatocellular carcinoma Cnot9 , Dicer1 , Xpo5 hereditary breast ovarian cancer syndrome Drosha Hereditary Neoplastic Syndromes Dcp2 , Dicer1 hereditary spastic paraplegia 53 Cnot7 holoprosencephaly Cnot1 holoprosencephaly 12 Cnot1 homocystinuria Adarb1 human immunodeficiency virus infectious disease Ran Huntington's disease Xpo5 Hyperphosphatemic Familial Tumoral Calcinosis 1 Dcp1b immunodeficiency 17 Ddx6 immunodeficiency 18 Ddx6 immunodeficiency 19 Ddx6 immunodeficiency 42 Adar infantile Refsum disease Xpo5 infertility Dicer1 inflammatory bowel disease 28 Ddx6 INTELLECTUAL DEVELOPMENTAL DISORDER WITH IMPAIRED LANGUAGE AND DYSMORPHIC FACIES Ddx6 Intellectual Developmental Disorder with Nasal Speech, Dysmorphic Facies, and Variable Skeletal Anomalies Cnot2 Intellectual Developmental Disorder with Speech Delay, Autism, and Dysmorphic Facies Cnot3 intellectual disability Ago1 , Cnot1 , Cnot3 , Dgcr8 , Patl1 , Tnrc6c isolated microphthalmia 5 Ddx6 Keloid Ran Lead Poisoning Xpo5 learning disability Adar LESSEL-KREIENKAMP SYNDROME Ago2 leukocyte adhesion deficiency 3 Patl1 liver benign neoplasm Tut4 liver cirrhosis Adar Liver Neoplasms Dicer1 long QT syndrome Dcp1b long QT syndrome 10 Ddx6 lung cancer Dicer1 lung non-small cell carcinoma Xpo5 lung small cell carcinoma Xpo5 male infertility Cnot7 , Drosha malignant mesothelioma Ago1 , Ago2 medulloblastoma Dicer1 megacolon Dgcr8 MHC class II deficiency Adar microcephaly Adar , Adarb1 microphthalmia Dicer1 Microsatellite Instability Tarbp2 , Xpo5 middle cerebral artery infarction Dicer1 morphine dependence Ago2 Multinodular Goiter 1 Dicer1 multiple myeloma Xpo5 myeloid leukemia Ago2 Myoclonic Epilepsies Tnrc6a myofibrillar myopathy 1 Cnot9 nephroblastoma Dgcr8 , Dicer1 , Drosha , Xpo5 nephroma Dicer1 nephrotic syndrome type 2 Xpo5 neurodevelopmental disorder with dysmorphic facies and distal limb anomalies Tnrc6b Neurodevelopmental Disorder with Hypotonia, Microcephaly, and Seizures Adarb1 NEURODEVELOPMENTAL DISORDER WITH LANGUAGE DELAY AND BEHAVIORAL ABNORMALITIES, WITH OR WITHOUT SEIZURES Ago1 Neurodevelopmental Disorders Adarb1 , Ago1 , Ago2 , Cnot1 , Cnot2 , Cnot9 , Dcp2 , Dgcr8 , Drosha , Tarbp2 , Tnrc6b obesity Adarb1 oligospermia Dicer1 osteoarthritis Ran ovarian cancer Dicer1 pancreatic cancer Xpo5 papillomavirus infectious disease Adar parathyroid carcinoma Adar paroxysmal nonkinesigenic dyskinesia 1 Cnot9 Pierson syndrome Dicer1 pineoblastoma Dicer1 pleuropulmonary blastoma Dicer1 polycystic ovary syndrome Adarb1 , Tnrc6b Preterm Intraventricular Hemorrhage Cnot1 primary ciliary dyskinesia Adarb1 primary immunodeficiency disease Dgcr8 primary ovarian insufficiency Xpo5 primary ovarian insufficiency 3 Ago2 progressive myoclonus epilepsy Adarb1 prostate adenocarcinoma Cnot9 Prostatic Neoplasms Cnot3 Pulmonary Atresia Pabpc1 RASopathy Ddx6 retinoblastoma Dicer1 rhabdomyosarcoma Dicer1 rheumatoid arthritis Ddx6 Salmonella Infections, Animal Adar schizophrenia Dgcr8 , Edc3 sciatic neuropathy Ran severe congenital neutropenia 3 Adar severe congenital neutropenia 5 Adar skin melanoma Cnot9 Spinal Cord Injuries Adarb1 stomach cancer Adar , Dicer1 subserous uterine fibroid Tnrc6b supratentorial primitive neuroectodermal tumor Dicer1 syndromic intellectual disability Adarb1 syndromic microphthalmia 5 Dicer1 T-cell acute lymphoblastic leukemia Cnot3 teratoma Ddx6 , Pabpc1 transient cerebral ischemia Adarb1 transitional cell carcinoma Cnot9 , Pabpc1 , Xpo5 type 1 diabetes mellitus Ran urinary bladder cancer Pabpc1 uterine fibroid Tnrc6b velocardiofacial syndrome Dgcr8 Venous Thrombosis Dgcr8 Viral Myocarditis Adar Vissers-Bodmer syndrome Cnot1 visual epilepsy Adarb1 withdrawal disorder Ago2 Zellweger syndrome Xpo5